JP5733601B2 - 劇症型炎症の予防および/または治療剤 - Google Patents
劇症型炎症の予防および/または治療剤 Download PDFInfo
- Publication number
- JP5733601B2 JP5733601B2 JP2010159031A JP2010159031A JP5733601B2 JP 5733601 B2 JP5733601 B2 JP 5733601B2 JP 2010159031 A JP2010159031 A JP 2010159031A JP 2010159031 A JP2010159031 A JP 2010159031A JP 5733601 B2 JP5733601 B2 JP 5733601B2
- Authority
- JP
- Japan
- Prior art keywords
- fulminant
- inflammation
- therapeutic agent
- preventive
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010159031A JP5733601B2 (ja) | 2010-07-13 | 2010-07-13 | 劇症型炎症の予防および/または治療剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010159031A JP5733601B2 (ja) | 2010-07-13 | 2010-07-13 | 劇症型炎症の予防および/または治療剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012020953A JP2012020953A (ja) | 2012-02-02 |
| JP2012020953A5 JP2012020953A5 (enExample) | 2013-09-05 |
| JP5733601B2 true JP5733601B2 (ja) | 2015-06-10 |
Family
ID=45775519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010159031A Active JP5733601B2 (ja) | 2010-07-13 | 2010-07-13 | 劇症型炎症の予防および/または治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5733601B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240115589A1 (en) | 2021-02-15 | 2024-04-11 | Kinki University | Pharmaceutical composition for preventing cytokine storm |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002014338A1 (fr) * | 2000-08-17 | 2002-02-21 | The Kitasato Institute | Nouveaux derives de pseudoerythromycine |
-
2010
- 2010-07-13 JP JP2010159031A patent/JP5733601B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012020953A (ja) | 2012-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wong et al. | Avian influenza virus infections in humans | |
| US12458622B2 (en) | Methods of treatment of coronavirus-induced inflammation conditions | |
| CN103687599A (zh) | 氯喹或氯丙嗪或其衍生物或它们的混合物在制备用于治疗和/或预防肺感染和损伤的药物中的用途 | |
| Smeenk et al. | Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis | |
| US20180185404A1 (en) | Compositions and methods for the treatment of viral infection | |
| CN111803645B (zh) | S100a8\a9二聚体活性抑制剂在防治或诊断冠状病毒感染中的用途 | |
| JP2026076345A (ja) | 抗ウイルス処置としてのアゼラスチン | |
| Onufer et al. | Influenza virus-induced type I interferons disrupt alveolar epithelial repair and tight junction integrity in the developing lung | |
| JP7752675B2 (ja) | ウイルスに対するタウロリジンの使用 | |
| JP2012020953A (ja) | 劇症型炎症の予防および/または治療剤 | |
| Chakinala et al. | Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences | |
| KR101879936B1 (ko) | 신규한 조류 인플루엔자 h5n9 재조합 바이러스 및 이를 포함하는 백신 조성물 | |
| Gabriel et al. | Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus | |
| Kilham et al. | Production of interferon during rat virus infection | |
| Fabbri et al. | Hantavirus pulmonary syndrome in the United States | |
| WO2023034718A1 (en) | Treatment of lower respiratory tract infection with tradipitant | |
| WO2023070058A1 (en) | Treatment of viruses with antiviral nucleosides | |
| CN113730461A (zh) | 血必净注射液在制备抑制IP-10和RANTES的mRNA表达的药物中的应用 | |
| Van den Bosch et al. | Asthma, eosinophilic pleuropneumonia, and pericarditis without vasculitis | |
| CN111888355A (zh) | 盐酸阿比朵尔在制备用于治疗脓毒症疾病的药物中的应用 | |
| RU2842052C1 (ru) | Азеластин в качестве противовирусного лечения | |
| Yakovlev et al. | Comparative study of the pathogenicity of SARS-CoV-2 B. 1 AND B. 1.617. 2 lineages for syrian hamsters | |
| RU2858638C1 (ru) | РЕКОМБИНАНТНЫЙ ШТАММ ВИРУСА ГРИППА RH2NBr (H2NB) ДЛЯ ОПРЕДЕЛЕНИЯ АНТИТЕЛ К НЕЙРАМИНИДАЗЕ ПРИ ГРИППОЗНОЙ ИНФЕКЦИИ И ВАКЦИНАЦИИ | |
| TWI764284B (zh) | 使用喹啉化合物來對抗冠狀病毒感染的方法 | |
| WO2011004843A1 (ja) | Sirsまたは強毒性インフルエンザ感染症処置のための医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130712 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130712 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20130712 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131008 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131128 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131219 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140805 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141006 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150303 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150402 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5733601 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |